Alveo and AGBL Team Up to Scale On-Farm Avian Influenza Diagnostics

The continuous threat of avian influenza remains one of the most critical operational and economic hazards for the global poultry sector. Rapid detection is essential to prevent devastating flock culls and severe supply chain disruptions that can affect everything from table egg availability to export quotas across Europe and neighboring regions.

Addressing this pressing need, Alveo Technologies has announced a strategic partnership with Alliance Global (AGBL) to distribute its advanced molecular diagnostic testing systems. The collaboration focuses on expanding access to rapid, on-farm testing tools designed to identify pathogens quickly before an outbreak spirals out of control within a production facility.

Unlike traditional laboratory-based assays that can take days to return results, on-farm molecular platforms empower veterinarians and farm managers to screen birds on-site and receive actionable data in real-time. This capability significantly shortens the decision-making window for quarantine, biosecurity enforcement, and veterinary intervention, protecting tight profit margins in intensive poultry farming.

As regulatory scrutiny tightens and biosecurity protocols become more stringent throughout major agricultural markets, the integration of portable diagnostic technology is shifting from a luxury to a baseline requirement. Poultry producers are increasingly looking for digital and molecular tools that can seamlessly integrate into daily health management routines without requiring specialized laboratory personnel.

While this partnership initially targets regions across Africa, Central Asia, and the Eastern Mediterranean, the broader trend toward decentralized, point-of-need diagnostics has direct implications for European and neighboring livestock producers. As mobile testing becomes more robust and cost-effective, farm-level disease surveillance will likely become a standard pillar of preventative veterinary medicine worldwide.